![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/18 | (2006.01) |
(11) | Number of the document | 2046833 |
(13) | Kind of document | T |
(96) | European patent application number | 07840408.4 |
Date of filing the European patent application | 2007-07-13 | |
(97) | Date of publication of the European application | 2009-04-15 |
(45) | Date of publication and mention of the grant of the patent | 2013-08-21 |
(46) | Date of publication of the claims translation | 2013-12-27 |
(86) | Number | PCT/US2007/073504 |
Date | 2007-07-13 |
(87) | Number | WO 2008/011348 |
Date | 2008-01-24 |
(30) | Number | Date | Country code |
06014730 | 2006-07-14 | EP | |
06020765 | 2006-10-02 | EP | |
943289 P | 2007-06-11 | US | |
943499 P | 2007-06-12 | US |
(72) |
PFEIFER, Andrea, CH
PIHLGREN, Maria, CH
MUHS, Andreas, CH
WATTS, Ryan, US
|
(73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
AC Immune S.A., EPFL Innovation Park Building B, 1015 Lausanne, CH |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Humanizuotas antikūnas prieš beta amiloidą |
HUMANIZED ANTIBODY AGAINST AMYLOID BETA |
Payment date | Validity (years) | Amount | |
2025-06-19 | 19 | 347.00 EUR |
2026-07-13 |